# A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

> **NCT07698600** · PHASE1 · RECRUITING · sponsor: **BioNTech SE** · enrollment: 126 (estimated)

## Conditions studied

- HIV -1 Infection

## Interventions

- **BIOLOGICAL:** BNT168
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07698600
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-04
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698600, "A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*